Novartis Investigative Site

Piraeus 18537

0 studies enrolling now · 5 studies all time

What they study most

Acromegaly, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HF-rEF), Leukaemia, Lymphocytic, Chronic, Lymphoma, Follicular

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly — Completed